The latest closing stock price for Neuphoria Therapeutics as of February 07, 2025 is 4.69.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-682 today, roughly -1 times their original investment - a -31.72% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 16.09, which is 243.1% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 54.8% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 7.89.
An investor who bought $1,000 worth of Neuphoria Therapeutics stock at the IPO in 2021 would have $-682 today, roughly -1 times their original investment - a -31.72% compound annual growth rate over 3 years.
The all-time high Neuphoria Therapeutics stock closing price was 14.73 on December 16, 2021.
The Neuphoria Therapeutics 52-week high stock price is 16.09, which is 243.1% above the current share price.
The Neuphoria Therapeutics 52-week low stock price is 2.12, which is 54.8% below the current share price.
The average Neuphoria Therapeutics stock price for the last 52 weeks is 7.89.